Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9107 |
High Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.9036 |
High Similarity |
NPD749 |
Clinical (unspecified phase) |
0.8976 |
High Similarity |
NPD482 |
Approved |
0.8882 |
High Similarity |
NPD2092 |
Phase 2 |
0.8882 |
High Similarity |
NPD2094 |
Phase 2 |
0.8882 |
High Similarity |
NPD2095 |
Phase 2 |
0.883 |
High Similarity |
NPD2091 |
Phase 2 |
0.883 |
High Similarity |
NPD2096 |
Phase 2 |
0.869 |
High Similarity |
NPD750 |
Phase 2 |
0.8462 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.8427 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.8254 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.8229 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.8171 |
Intermediate Similarity |
NPD4079 |
Approved |
0.8171 |
Intermediate Similarity |
NPD4076 |
Approved |
0.8158 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD8431 |
Approved |
0.8138 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.8138 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.8128 |
Intermediate Similarity |
NPD8072 |
Approved |
0.8115 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.8115 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.8114 |
Intermediate Similarity |
NPD2144 |
Approved |
0.8114 |
Intermediate Similarity |
NPD3505 |
Approved |
0.8114 |
Intermediate Similarity |
NPD3506 |
Approved |
0.8108 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.8103 |
Intermediate Similarity |
NPD5065 |
Approved |
0.809 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.809 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.8087 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.8087 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.8085 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.8083 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD8073 |
Approved |
0.8066 |
Intermediate Similarity |
NPD4499 |
Approved |
0.8057 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.8045 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD1722 |
Approved |
0.8012 |
Intermediate Similarity |
NPD786 |
Approved |
0.8012 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.8011 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7978 |
Intermediate Similarity |
NPD4383 |
Clinical (unspecified phase) |
0.7968 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7968 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7968 |
Intermediate Similarity |
NPD484 |
Approved |
0.7952 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.795 |
Intermediate Similarity |
NPD2896 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.7926 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7884 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.7872 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.7865 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7849 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7846 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD4345 |
Clinical (unspecified phase) |
0.7814 |
Intermediate Similarity |
NPD7234 |
Approved |
0.7814 |
Intermediate Similarity |
NPD7233 |
Approved |
0.7812 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7809 |
Intermediate Similarity |
NPD4181 |
Approved |
0.7803 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD4462 |
Approved |
0.7798 |
Intermediate Similarity |
NPD4463 |
Approved |
0.7797 |
Intermediate Similarity |
NPD4128 |
Approved |
0.7795 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7795 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7765 |
Intermediate Similarity |
NPD5257 |
Clinical (unspecified phase) |
0.776 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.7749 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7727 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7725 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD276 |
Clinical (unspecified phase) |
0.7708 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.7684 |
Intermediate Similarity |
NPD6479 |
Discontinued |
0.768 |
Intermediate Similarity |
NPD2509 |
Approved |
0.768 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7679 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7679 |
Intermediate Similarity |
NPD4703 |
Approved |
0.767 |
Intermediate Similarity |
NPD4638 |
Approved |
0.767 |
Intermediate Similarity |
NPD4639 |
Approved |
0.767 |
Intermediate Similarity |
NPD2641 |
Approved |
0.767 |
Intermediate Similarity |
NPD4640 |
Approved |
0.767 |
Intermediate Similarity |
NPD2640 |
Approved |
0.7667 |
Intermediate Similarity |
NPD8386 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD1534 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5003 |
Discontinued |
0.7617 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD5611 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD1403 |
Approved |
0.7586 |
Intermediate Similarity |
NPD1404 |
Approved |
0.7584 |
Intermediate Similarity |
NPD3609 |
Approved |
0.7584 |
Intermediate Similarity |
NPD3610 |
Approved |
0.7568 |
Intermediate Similarity |
NPD4948 |
Discontinued |
0.7565 |
Intermediate Similarity |
NPD6176 |
Phase 1 |
0.7553 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD5818 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD3943 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD5898 |
Approved |
0.7527 |
Intermediate Similarity |
NPD5897 |
Approved |
0.7527 |
Intermediate Similarity |
NPD5899 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7514 |
Intermediate Similarity |
NPD2639 |
Approved |
0.7514 |
Intermediate Similarity |
NPD2642 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7187 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5254 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5043 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3394 |
Approved |
0.75 |
Intermediate Similarity |
NPD3583 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3389 |
Approved |
0.75 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3393 |
Approved |
0.7488 |
Intermediate Similarity |
NPD7824 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6846 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6454 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD4779 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD5471 |
Phase 3 |
0.7457 |
Intermediate Similarity |
NPD2809 |
Approved |
0.745 |
Intermediate Similarity |
NPD7970 |
Approved |
0.745 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD4918 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD4112 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD972 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD5975 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD6217 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD3404 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5505 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD6635 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2564 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2565 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7731 |
Approved |
0.7389 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD2511 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7950 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7790 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7789 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7953 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7952 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7791 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7951 |
Approved |
0.7379 |
Intermediate Similarity |
NPD7271 |
Approved |
0.7374 |
Intermediate Similarity |
NPD5021 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD4326 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD1038 |
Approved |
0.7351 |
Intermediate Similarity |
NPD3319 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD3320 |
Approved |
0.7351 |
Intermediate Similarity |
NPD3318 |
Approved |
0.7337 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD5473 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD4427 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD4500 |
Approved |
0.732 |
Intermediate Similarity |
NPD2305 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD4501 |
Approved |
0.7318 |
Intermediate Similarity |
NPD4554 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD6026 |
Approved |
0.7314 |
Intermediate Similarity |
NPD2580 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD5322 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD6281 |
Approved |
0.7294 |
Intermediate Similarity |
NPD751 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD5472 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1592 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD7781 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7780 |
Approved |
0.7268 |
Intermediate Similarity |
NPD5100 |
Phase 3 |
0.726 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD6323 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD5213 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD5105 |
Approved |
0.7258 |
Intermediate Similarity |
NPD5106 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6277 |
Clinical (unspecified phase) |
0.724 |
Intermediate Similarity |
NPD4602 |
Approved |
0.7235 |
Intermediate Similarity |
NPD4637 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD7865 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6665 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD4922 |
Phase 2 |
0.7222
|
Intermediate Similarity |
NPD7010 |
Phase 3 |